Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

0(0%)

Results Posted

57%(4 trials)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

7(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 17 (100.0%)

Trials by Status

completed7100%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

NCT03792477

completedphase_1

Paxil CR Bioequivalence Study Brazil

NCT01316926

completedphase_1

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

NCT03443089

completedphase_1

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

NCT01262989

completedphase_1

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

NCT01330303

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03792477Phase 1

A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males

Completed

NCT01316926Phase 1

Paxil CR Bioequivalence Study Brazil

Completed

NCT03443089Phase 1

Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate

Completed

NCT01262989Phase 1

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin

Completed

NCT01330303Phase 1

SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin

Completed

NCT01823900Phase 1

Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

Completed

NCT01823913Phase 1

Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

Completed

All 7 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 7